Press Release
Aug 07, 2022
Contact: Chris Martin, IASLC Media Relations, cmartin@davidjamesgroup.com, 630.670.2745
What: The International Association for the Study of Lung Cancer (IASLC) 2022 World Conference on Lung Cancer Presidential Symposium Press Briefing
When: Monday, August 8, 2022, at 10:30 a.m. CEST
Where: For journalists covering the meeting onsite, the press briefings will be held in Room Location: Schubert 5-6, Upper Level, Congress Centre.
Zoom Link: For journalists covering the meeting remotely, the Zoom link for the press briefing is: https://us02web.zoom.us/j/86466157970
About: Each IASLC World Conference on Lung Cancer highlights the best in lung cancer research. Each press briefing will be moderated by an IASLC member and include an IASLC Patient Advocate, to provide a unique perspective on how research may affect patients coping with lung cancer.
Moderator: Dr. Heather Wakelee
Patient Advocate: Christina Sit
Panelists:
- Abstract 1863: Personalized smoking cessation support in a lung cancer screening program: The Yorkshire Enhanced Stop Smoking Study (YESS) Dr. Rachael Murray
- Abstract 3051: Lobar or Sub-lobar Resection for Peripheral Clinical Stage IA = 2 cm Non-small Cell Lung Cancer (NSCLC): Results from an International Randomized Phase III Trial (CALGB 140503 [Alliance])—Dr. Nasser Altkori
- Abstract 1988: Progression Free Survival and Overall Survival in NADIM II Study — Dr. Mariano Provencio
- Abstract: 2332 IMpower010: Overall Survival Interim Analysis of a Phase III Study of Atezolizumab vs Best Supportive Care in Resected NSCLC—Dr. Enriqueta Felip
Recordings of the press briefings will be sent after the briefing concludes.
Embargoes: abstracts that are part of the press program will be embargoed for beginning of each day’s press briefing. The IASLC reserves the right to change an embargo to account for a journal publication or other issues.
Media Registration: If you have not registered to cover the meeting, visit https://wclc2022.iaslc.org/press-media/.
# # #
About the IASLC:
The International Association for the Study of Lung Cancer (IASLC) is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes nearly 7,500 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis, and treatment of all thoracic malignancies. Visit www.iaslc.org for more information.
About the WCLC:
The WCLC is the world’s largest meeting dedicated to lung cancer and other thoracic malignancies, attracting more than 7,000 researchers, physicians and specialists from more than 100 countries. The goal is to increase awareness, collaboration and understanding of lung cancer, and to help participants implement the latest developments across the globe. The conference will cover a wide range of disciplines and unveil several research studies and clinical trial results. For more information, visit https://wclc2022.iaslc.org/